Daytrana and condition aggravated Patient Reports February 13, 2012

Daytrana Side Effects Report #5159017-4
Daytrana side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 10, 2006. Male patient, child 9 years of age, weighting 63.05 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: condition aggravated, convulsion. Daytrana dosage: 10 MG X 2, TRANSDERMAL; 10 MG, TRANSDERMAL. During the same period patient was treated with TRACROLIMUS, VALGANCICLOVIR, METOCLOPRAMIDE, PRILOSEC, KEPPRA, TRILEPTAL, VITAMINS. Patient recovered.

Daytrana Side Effects Report #6075404-4
Daytrana side effect was reported by a Health Professional from UNITED STATES on Jan 27, 2009. Male patient, 15 years of age, weighting 110.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: anterior chamber cleavage syndrome, condition aggravated, off label use, somnolence. Daytrana dosage: 20 MG, 1X/DAY:QD, ORAL. During the same period patient was treated with EYE DROPS. Patient recovered.

Daytrana Side Effects Report #5140533-6
Daytrana side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2006. Male patient, 13 years of age, weighting 80.03 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: aggression, condition aggravated, homicidal ideation, oppositional defiant disorder. Daytrana dosage: 20 MG, TRANSDERMAL. Patient recovered.

Daytrana Side Effects Report #5989365-7
Daytrana side effect was reported by a Pharmacist from UNITED STATES on Nov 21, 2008. Male patient was treated with Daytrana. After drug was administered, patient experienced the following side effects: adverse event, condition aggravated, crohn's disease , device failure, off label use, product quality issue. Daytrana dosage: unknown. During the same period patient was treated with PREDNISONE, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.